Dr. Michael Anglesio and Dr. Aline Talhouk talk with UBC's Faculty of Medicine about a new ovarian cancer test PrOTYPE. This new test they helped develop is used to help classify a patient's tumor into of one of four known subtypes of ovarian cancer, opening the future to more individualistic approach to treatment.
Learn more at : https://www.med.ubc.ca/news/new-test-paves-the-way-for-tailored-treatment-of-deadliest-form-of-ovarian-cancer/
Read the publication of PrOTYPE here: https://pubmed.ncbi.nlm.nih.gov/32554541/
(OR DOI doi: 10.1158/1078-0432.CCR-20-0103)
Comments